Tobacco use among substance use disorder (SUD) treatment staff is associated with tobacco-related services received by clients.

Journal of Substance Abuse Treatment
Joseph GuydishKevin Delucchi

Abstract

Despite disproportionately high rates of smoking among people in residential substance use disorder (SUD) treatment, few receive tobacco cessation services. Little is known about how smoking among treatment staff may impact this disparity. We explored the relationship between staff tobacco use and client tobacco use. Additionally, we examined the relationship between staff tobacco use and tobacco-related services reported by staff and clients. Staff (n = 363) and clients (n = 639) in 24 California publicly-funded residential SUD treatment programs were surveyed in 2019-20. Staff self-reported current tobacco use, as well as their beliefs, self-efficacy, and practices regarding smoking cessation. Clients reported their tobacco use and they services received while in treatment. Regression analyses examined the adjusted and unadjusted associations between staff and client tobacco use and other outcomes. Use of any tobacco product by staff ranged from 0% to 100% by program, with an average of 32% across programs. Adjusted analyses found that higher rates of staff tobacco use were associated with higher rates of client tobacco use, and with fewer clients receiving tobacco-related counseling. In programs that had higher rates of staf...Continue Reading

References

Sep 1, 1995·Psychiatric Services : a Journal of the American Psychiatric Association·J K BoboA L Hoffman
Mar 1, 1993·Journal of Substance Abuse Treatment·J K Bobo, C M Davis
Jul 3, 1998·Journal of Substance Abuse Treatment·B K CampbellM J Stark
Aug 6, 1999·Journal of Substance Abuse Treatment·S M Bernstein, G Stoduto
Apr 3, 2001·Journal of Substance Abuse Treatment·B S Gill, D L Bennett
May 25, 2002·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·UNKNOWN SRNT Subcommittee on Biochemical Verification
Jul 23, 2002·Addiction·Kimber Paschall RichterJasjit S Ahluwalia
Jul 27, 2002·BMJ : British Medical Journal·Caroline M Fichtenberg, Stanton A Glantz
Dec 23, 2004·Journal of Consulting and Clinical Psychology·Judith J ProchaskaSharon M Hall
Mar 24, 2005·Journal of Addictive Diseases·Yngvild OlsenRichard Saitz
Jul 17, 2007·Health Affairs·Tami L MarkUNKNOWN SAMHSA Spending Estimates Team
Feb 29, 2008·Journal of Psychoactive Drugs·Joseph GuydishSarah Turcotte Manser
Aug 22, 2008·Journal of Substance Abuse Treatment·Catherine Theresa Baca, Carolina E Yahne
Feb 2, 2010·Journal of Substance Abuse Treatment·Hannah K Knudsen, Jamie L Studts
Jul 30, 2010·Journal of Substance Abuse Treatment·Margaret S ChisolmHendrée E Jones
Mar 1, 2009·Journal of Drug Issues·Kevin L DelucchiJoseph Guydish
Dec 24, 2010·The American Journal on Addictions·Tanja C Rothrauff, Lillian T Eby
Jun 8, 2011·The Journal of Behavioral Health Services & Research·Hannah K KnudsenJamie L Studts
Jul 22, 2011·The New England Journal of Medicine·Judith J Prochaska
May 1, 2012·Drug and Alcohol Dependence·Kenneth D WardGeorge E Relyea
Apr 15, 2014·Tobacco Control·Philip H SmithSherry A McKee
Jul 16, 2014·BMC Health Services Research·Camilla CooksonAnn McNeill
Feb 14, 2015·Administration and Policy in Mental Health·Jessica L MuilenburgNancy D Moore
May 26, 2015·Journal of Addictive Behaviors, Therapy & Rehabilitation·Tanja C LaschoberLillian T Eby
May 28, 2015·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Anna PaganoKevin L Delucchi
Jun 18, 2016·The American Journal of Drug and Alcohol Abuse·Hannah K Knudsen
Jul 28, 2016·Drug and Alcohol Dependence·Joseph GuydishPaul Roman
Feb 2, 2017·Journal of Substance Abuse Treatment·Joseph GuydishKevin Delucchi
Jan 12, 2019·Psychiatric Services : a Journal of the American Psychiatric Association·Joseph GuydishKevin L Delucchi
Sep 20, 2019·American Journal of Public Health·Amy Y HafezStanton A Glantz
Jul 22, 2020·Drug and Alcohol Dependence·Joseph GuydishKevin Delucchi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Behavioral Health Services & Research
J Randy Koch, Alison Breland
Journal of Clinical and Diagnostic Research : JCDR
Sabiha Shaheen ShaikSuhas Kulkarni
Cancer Research
Kasisomayajula ViswanathWriting Committee for the AACR Task Force on Tobacco and Cancer
© 2021 Meta ULC. All rights reserved